Schaeffer's Top Stock Picks for '25

The Obamacare Fears Crushing this Insurance Stock

Uncertainty over federal subsidies is sinking Centene stock

Managing Editor
Oct 24, 2017 at 2:23 PM
facebook X logo linkedin


Stocks are significantly higher this afternoon, with the Dow hitting a fresh record high. Healthcare company Centene Corp (NYSE:CNC) is down, while Jeep parent Fiat Chrysler Automobiles NV (NYSE:FCAU) and biotech stock Pain Therapeutics, Inc. (NASDAQ:PTIE) are enjoying breakout sessions. Here's a quick look at what is moving shares of CNC, FCAU, and PTIE.

CNC Stock Plummets Over Federal Subsidy Uncertainties 

Centene stock is down 3.8% to trade at $94.29, dipping lower after the healthcare company predicted it could lose 7-12 cents off its fourth-quarter earnings due to President Trump's decision to cut off Obamacare subsidies. However, the shares have found familiar support from its 50-day moving average, and is still up 66% year-to-date. Meanwhile, analysts may need to reconsider their bullish positions. Of the 16 brokerages that cover CNC, 12 rate the shares a "buy" or "strong buy."

Fiat Chrysler Stock Flirting With Record Highs After Earnings Beat

This morning, Fiat Chrysler joined rival General Motors in reporting third-quarter earnings that exceeded Wall Street expectations. The news has FCAU stock up 5.8% to trade at $17.51, and flirting with the record high of $18.10 it set on Sept. 22. It's been a stellar run for the equity, adding a whopping 172% year-over-year, and it has outperformed the broader S&P 500 Index (SPX) by nearly 32 percentage points during the past three months.

In the options pits, call buying has been vastly more popular than put buying in recent months at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). This is according to the equity's 50-day call/put volume ratio of 5.12, which ranks in the 86th percentile of its annual range.

Pain Therapeutics Top Of The Nasdaq After Alzheimer's Drug News

Pain Therapeutics stock is up over 38% to trade at $5.14, after PTI-125, the biotech's experimental drug for Alzheimer's, succeeded in early stage testing. The news takes PTIE stock to its highest point since April, but it topped out right at its 320-day moving average. Short sellers are likely sweating this sudden surge nonetheless. While short interest has decreased by 2% during the last reporting period, it accounts for 10% of the total available float. 
 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?